Exhibiting at the Oncology Convention


IndiTreat®, functional profiling to match effective cancer drug treatment with individual cancer patients.

2cureX was founded in 2006 as a spin-out from the Carlsberg Research center in Copenhagen, with the vision of improving treatment efficiency for cancer patients. From its inception, 2cureX has been closely related to the major Cancer hospitals in the Nordics, Germany and the UK. 2cureX developed the IndiTreat® test; IndiTreat® matches the individual cancer patient with the most effective cancer treatment. The IndiTreat® test for colorectal cancer has a European CE-IVD approval and the company is conducting ongoing multi-centre clinical trials with leading Cancer hospitals within Colorectal cancer, Ovarian Cancer and Pancreatic Cancer.

Visit Website